Stemchymal® is Steminent’s proprietary technology platform generating the standardized, clinical grade, allogeneic stem cells isolated from human adipose tissue. It is operated in strict compliance to regulations of Taiwan, the US, and Japan.

The Stemchymal® technology platform enables the isolation, processing and production of highly purified, potent stem cell product from adipose tissues. It also further makes it possible to massively expand the patented stem cells while maintaining highly consistent cell identity and functionality of the desired cell population.